Ammonia → HCID 12680078, compound
Reaction equation
[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[NH:11][C:10](=S)[CH2:9][N:8]=[C:7]([C:13]3[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=3)[C:6]=2[CH:19]=1.[NH3:20].CO>O1CCCC1>[NH2:20][C:10]1[CH2:9][N:8]=[C:7]([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=2)[C:6]2[CH:19]=[C:2]([Br:1])[CH:3]=[CH:4][C:5]=2[N:11]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
59.5 g of 7-bromo-5-(2-pyridyl)-3H-1,4-benzodiazepine-2(1H)-thione (J. B. Hester, jr., A. D. Rudzik & P.F . Von Voigtlander, J. Med. Chem., 1980,23, 392-402) in 800 ml of tetrahydrofuran were added to 1.0 l of 25% aqueous ammonia solution and 300 ml of methanol. The mixture was stirred at room temperature for 16 h., with the solution which formed being concentrated to about 500 ml in a vacuum. The crystals were filtered off, washed with water and dried. There were obtained 52 g of 2-amino-7-bromo-5-(2-pyridyl)-3H-1,4-benzodiazepine which was used without further purification for the next step. A sample recrystallized from dioxan melted at 213-215° C. (dec.).
Workup
- customformed
- concentrationbeing concentrated to about 500 ml in a vacuum
- filtrationThe crystals were filtered off
- washwashed with water
- customdried
Sources & evidence
- ORD record
- ord-b52a0081cab6486f9bc194e057778828
- Source dataset
- uspto-grants-2001_01
- Patent number
- US06174881B1
Reaction notes
Loading…